SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 147 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $192,000 | -28.9% | 12,800 | -58.3% | 0.03% | -15.4% |
| Q2 2017 | $270,000 | +280.3% | 30,700 | +124.1% | 0.04% | +1850.0% |
| Q1 2017 | $71,000 | -10.1% | 13,700 | -19.4% | 0.00% | -90.9% |
| Q3 2016 | $79,000 | -9.2% | 17,000 | +12.6% | 0.02% | -81.8% |
| Q2 2016 | $87,000 | -63.0% | 15,100 | -61.2% | 0.12% | +19.8% |
| Q1 2016 | $235,000 | -67.4% | 38,900 | -15.3% | 0.10% | -32.2% |
| Q1 2015 | $720,000 | +27.4% | 45,900 | +24.1% | 0.15% | -43.6% |
| Q2 2014 | $565,000 | – | 37,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |